Hypoxia and the Edema Syndrome: Elucidation of a mechanism of teratogenesis

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 89, Issue 4, 2010, Pages 300-303

  Chernoff, Neil ^a   Rogers, John M ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Edema syndrome; Hypoxia; Teratogenesis

Indexed keywords

ADRENALIN; ANTICONVULSIVE AGENT; COCAINE; FREE RADICAL; HYDROXYUREA; MISOPROSTOL; PHENYTOIN; POTASSIUM CHANNEL BLOCKING AGENT;

BIRTH DEFECT; BLEEDING; BLISTER; CHICK EMBRYO; EDEMA; EDEMA SYNDROME; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; HEMATOMA; HUMAN; HYPOXIA; NONHUMAN; OSMOREGULATION; PATHOGENESIS; PHENOTYPE; PLACENTA CIRCULATION; PRIORITY JOURNAL; REVIEW; SYNDROME; TERATOGENESIS; TERATOGENICITY; VASOCONSTRICTION;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANOXIA; BLISTER; CHICK EMBRYO; COCAINE; EDEMA; EPINEPHRINE; HEMATOMA; HEMORRHAGE; HYDROXYUREA; PHENYTOIN; POTASSIUM CHANNEL BLOCKERS; SYNDROME;

MAMMALIA;

EID: 77955914531     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.20258     Document Type: Review

References (47)

1. Abrahamsson C, Palmer M, Ljung B, Duker G, Baarnhielm C, Carlsson L, Danielsson B. 1994. Induction of rhythm abnormalities in the fetal rat heart: a tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant. Cardiovasc Res 28:337-344. (Pubitemid 24131070)
2. Azarbayjani F, Danielsson BR. 1998. Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: a common teratogenic mechanism for antiepileptic drugs? Teratology 57:117-126.
3. Azarbayjani F, Danielsson BR. 2002. Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs? Epilepsia 43:457-468.
4. Brent RL, Franklin JB. 1960. Uterine vascular clamping: new procedure for the study of congenital malformations. Science 132:89-91.
5. Chernoff N, Grabowski CT. 1971. Responses of the rat fetus to injections of epinephrine and vasopressin. Br J Pharmacol 43:270-278.
6. Church MW, Dintcheff BA, Gessner PK. 1988. Dose-dependent consequences of cocaine on pregnancy outcome in the Long-Evans rat. Neurotoxicol Teratol 10:51-58.
7. Clark KE, Irion GL. 1992. Fetal hemodynamic response to maternal intravenous nicotine administration. Am J Obstet Gynecol 167: 1624-1631.
8. Danielson MK, Danielsson BR, Marchner H, Lundin M, Rundqvist E, Reiland S. 1992. Histopathological and hemodynamic studies supporting hypoxia and vascular disruption as explanation to phenytoin teratogenicity. Teratology 46:485-497.
9. Danielsson BR, Azarbeyjani F, Skold A-C, Webster WS. 1997. Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation. Teratology 56:271-281.
10. Danielsson BR, Skold AC, Johansson A, Dillner B, Blomgren B. 2003. Teratogenicity by the hERG potassium channel blocking drug almokalent: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia. Toxicol Appl Pharmacol 193:168-176. (Pubitemid 37476432)
11. Dareste MC. 1877. The experimental production of birth defects. Paris: C. Reinwald et Cie.
12. Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS, Zhang XJ, Clark DA, Miller MJ. 1994. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruption in rats. Am J Obstet Gynecol 171:1243-1250. (Pubitemid 24365723)
13. Fantel AG, Barber CV, Mackler B. 1992. Ischemia/reperfusion: a new hypothesis for the developmental toxicity of cocaine. Teratology 46:285-292.
14. Fantel AG, Nekahi N, Shepard TH, Cornel LM, Unis AS, Lemire RJ. 1997. The teratogenicity of N(omega)-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor in rats. Reprod Toxicol 11:709-717. (Pubitemid 29110538)
15. Fantel AG, Stamps LD, Tran TT, Mackler B, Person RE, Nekahi N. 1999. Role of free radicals in the limb teratogenicity of L-NAME (N(G)-nitro-(L)-arginine methyl ester): a new mechanistic model of vascular disruption. Teratology 60:151-160. (Pubitemid 29429919)
16. Fisher JE, Potturi RB, Collins M, Resnick E, Zimmerman EF. 1994. Cocaine-induced embryonic cardiovascular disruption in mice. Teratology 49:182-191. (Pubitemid 24113771)
17. Grabowski CT. 1961a. A quantitative study of the lethal and teratogenic effects of hypoxia on the three-day chick embryo. Am J Anat 109: 25-36.
18. Grabowski CT. 1961b. Lactic acid accumulation as a cause of hypoxia-induced malformations in the chick embryo. Science 134:1359-1360.
19. Grabowski CT. 1963. Teratogenic significance of ionic and fluid imbalances. Science 142:1064-1065.
20. Grabowski CT. 1964. The etiology of hypoxia-induced malformations in the chick embryo. J Exp Zool 157:307-326.
21. Grabowski CT. 1966a. Physiological changes in the bloodstream of chick embryos exposed to teratogenic doses of hypoxia. Dev Biol 13: 199-213.
22. Grabowski CT. 1966b. Ontogenetic changes in the concentration of serum proteins in chick and mammalian embryos. J Embryol Exp Morphol 16:197-202.
23. Grabowski CT. 1966c. Teratogenic effects of calcium salts in chick embryos. J Embryol Exp Morphol 15:113-118.
24. Grabowski CT. 1967. Ontogenetic changes in the osmotic pressure and sodium and potassium concentrations of chick embryo serum. Comp Biochem Physiol 21:345-350.
25. Grabowski CT. 1981. Plasma proteins and colloid osmotic pressure of blood of rat fetuses prenatally exposed to Mirex. J Toxicol Environ Health 5:705-714.
26. Grabowski CT, Paar JA. 1958. The teratogenic effects of graded doses of hypoxia on the chick embryo. Am J Anat 103:313-348.
27. Grabowski CT, Payne DB. 1980. An electrocardiographic study of cardiovascular problems in mirex-fed rat fetuses. Teratology 22:167-177.
28. Grabowski CT, Schroeder RE. 1968. A time-lapse photographic study of chick embryos exposed to teratogenic doses of hypoxia. J Embryol Exp Morphol 19:347-362.
29. Grabowski CT, Tsai ET, Toben HR. 1969. The effects of teratogenic doses of hypoxia on the blood pressure of chick embryos. Teratology 2:67-76.
30. Gregg AR, Schauer A, Shi O, Liu Z, Lee CG, O'Brien WE. 1998. Limb reduction defects in endothelial nitric oxide synthase-deficient mice. Am J Physiol 275:H2319-H2324. (Pubitemid 128731601)
31. Hammer RTE, Goldman H, Mitchell JA. 1981. Effects of nicotine on uterine blood flow and intrauterine oxygen tension in the rat. J Reprod Fertil 63:163-168. (Pubitemid 12195700)
32. Hefler LA, Reyes CA, O'Brien WE, Gregg AR. 2001. Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod 64:666-673. (Pubitemid 32109757)
33. Hoyme HE, Jones KL, Dixon SD, Jewett T, Hanson JW, Robinson LK, Msall ME, Allanson JE. 1990. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85:743-747. (Pubitemid 20144846)
34. Jones KL. 1991. Developmental pathogenesis of defects associated with prenatal cocaine exposure: fetal vascular disruption. Clin Perinatol 18:139-146.
35. Millicovsky G, DeSesso JM, Kleinman LI, Clark KE. 1981. Effects of hydroxyurea on hemodynamics of pregnant rabbits: a maternally mediated mechanism of embryotoxicity. Am J Obstet Gynecol 140:747-752. (Pubitemid 11046638)
36. Moore TR, Sorg J, Miller L, Key TC, Resnick R. 1986. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am J Gynecol 155:883-888. (Pubitemid 17178350)
37. Morgan MA, Silavin SL, Randolph M, Payne GG, Sheldon RE, Fishburne JL, Wentworth RA, Nathanielsz PW. 1991. Effect of intravenous cocaine on blood flow in the gravid baboon. Am J Obstet Gynecol 164: 1027-1030.
38. Suzuki K, Minei LJ, Johnson EE. 1980. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol 136:1009-1013. (Pubitemid 10112853)
39. Tiboni GM, Giampietro F, Giulio C. 2003. The nitric synthesis inhibitor N-nitro-L-arginine methyl ester (L-NAME) causes limb defects in mouse fetuses: protective effect of acute hyperoxia. Pediatr Res 54:69-76. (Pubitemid 36736809)
40. Vargas FR, Schuler-Faccini L, Brunoni D, Kim C, Meloni VF, Sugayama SM, Albano L, Llerena Jr JC, Almeida JC, Duarte A, Cavalcante DP, Goloni-Bertollo E, Conte A, Koren G, Addis A. 2000. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet 95:302-306.
41. Webster WS, Lipson AH, Brown-Woodman PDC. 1987. The haemoglobin constitution of infants with the Haemoglobin Bart's hydrops foetalis syndrome. Br J Haematol 18:357-367.
42. Webster WS, Brown-Woodman PDC, Lipson AH, Ritchie HE. 1991. Fetal brain damage in the rat following prenatal exposure to cocaine. Neurotoxicol Teratol 13:621-626.
43. Webster WS, Brown-Woodman PD, Snow MD, Danielsson BR. 1996. Teratogenic potential of almokalent, dofetilide, and d-sotalol: drugs with potassium channel blocking activity. Teratology 53: 168-175.
44. Webster WH, Howe AM, Abela D, Oakes DJ. 2006. The relationship between cleft lip, maxillary hypoplasia, hypoxia and phenytoin. Curr Pharm Des 12:1431-1448. (Pubitemid 44082104)
45. Wilson JG. 1953. Influence of severe haemorrhagic anemia during pregnancy on development of offspring in the rat. Proc Soc Exp Biol Med 84:66-69.
46. Woods JR, Plessinger MA, Clark KE. 1987. Effect of cocaine on fetal blood flow and oxygenation. JAMA 257:957-961. (Pubitemid 17024390)
47. Zimmerman EF, Potturi RB, Resnick E, Fisher JE. 1994. Role of oxygen free radicals in cocaine-induced vascular disruption in mice. Teratology 49:192-201. (Pubitemid 24113772)